BioCardia (BCDA) Gross Margin Growth (3y) (2016 - 2021)
Powered by 
Analysis
BioCardia (BCDA) Gross Margin Growth (3y) (2016 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.44 Bn | 55.72 Mn | 81,745.00 |
| 4 | Legend Biotech | 3.62 Bn | 2.66 Bn | 251.50 Mn | 946.00 |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn | 4,983.00 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 9,094.00 |
| 8 | Sarepta Therapeutics | 2.25 Bn | 1.46 Bn | 251.87 Mn | -2,417.00 |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 762.00 |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 11,262.00 |
| Sep 30, 2021 | 12,976.00 |
| Jun 30, 2021 | 5,649.00 |
| Dec 31, 2020 | 16,500.00 |
| Sep 30, 2020 | 11,308.00 |
| Jun 30, 2020 | 18,125.00 |
| Mar 31, 2020 | 11,721.00 |
| Dec 31, 2019 | 10,542.00 |
| Sep 30, 2019 | 15,515.00 |
| Jun 30, 2019 | -11,376.00 |
| Mar 31, 2019 | 7,789.00 |
| Jun 30, 2016 | -10,833.00 |
| Mar 31, 2016 | -12,697.00 |